BHIANT Logo.png
BHIANT Celebrates Milestones in Workforce Development and Industry Collaboration, Sets Vision for 2025
17 déc. 2024 10h00 HE | BHIANT
DALLAS, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) proudly announces significant progress in workforce development and industry...
AliraHealth.jpg
Alira Health Secures Up to $100M Growth Debt Facility from Symbiotic Capital to Propel Strategic Expansion and Patient-Enabled Innovation
17 déc. 2024 09h00 HE | Alira Health
Alira Health announced today the securing of up to $100 million in growth debt from Symbiotic Capital, a premier healthcare and life sciences investor.
Avextra Logo.png
Avextra Supports First Fully EU-Funded Psilocybin Therapy Study, Now Approved by EMA
12 déc. 2024 07h00 HE | Avextra Pharma GmbH
Exclusive Industry Role: Avextra is the industry partner in the first EU-funded project focused on psychedelic-assisted therapy for patients in palliative care suffering from depression, with a total...
Image 1: Chameleon Discovery LX
Coherent Unveils Discovery LX Laser, Expanding the Chameleon Discovery Family
10 déc. 2024 07h30 HE | Coherent Corp.
Image 1: Chameleon Discovery LX PITTSBURGH, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in laser and photonics solutions, announces the launch of the Chameleon...
Priothera-Logo (002).png
Priothera to Present Trial in Progress Poster for Mocravimod at 2024 American Society of Hematology (ASH) Annual Meeting
03 déc. 2024 06h00 HE | Priothera
Mocravimod is being investigated in a global MO-TRANS Phase 3 study in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation Mocravimod is the only S1P receptor...
Ignite Awardees
Innovate BC Awards $1.5M to Five Research & Development Projects Advancing Clean Tech and Life Sciences Solutions in British Columbia
28 nov. 2024 17h48 HE | Innovate BC
Through its Ignite program, Innovate BC has awarded $1.5M across 5 B.C.-based R&D projects developing solutions that address priority challenges.
Avextra Logo.png
Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Establishing a Key IP Pillar
20 nov. 2024 07h00 HE | Avextra AG
Avextra Portugal launches an innovative in-house breeding program to develop proprietary cannabis varieties with specific, consistent and reproducible cannabinoid and terpene profiles.Over a two-year...
Kneat Logo 300 dpi.jpg
Kneat Achieves Record Results in Growth and Profitability
06 nov. 2024 17h04 HE | kneat.com, inc.
Kneat achieves record results in growth and profitability, as third-quarter 2024 revenue and gross profit growth accelerate to 52% and 78% respectively,
Kneat Logo 300 dpi.jpg
Global Medical Devices Manufacturer Selects Kneat to Digitize Validation
31 oct. 2024 17h13 HE | kneat.com, inc.
Kneat signs a global and diverse medical devices manufacturer for digital validation.
Kneat Logo 300 dpi.jpg
Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024
30 oct. 2024 17h17 HE | kneat.com, inc.
Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024, and Host an Earnings Call on November 7